We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
OMC
26
Overbrook Management Corp
New York
$921K
PHP
27
Parkman Healthcare Partners
Connecticut
$739K +$36.1K +7,106 +4%
UOC
28
UBS O'Connor
Illinois
$652K
Bank of New York Mellon
29
Bank of New York Mellon
New York
$593K -$2.86K -563 -0.4%
Nuveen
30
Nuveen
North Carolina
$579K
Marshall Wace
31
Marshall Wace
United Kingdom
$570K +$40.1K +7,876 +6%
Citadel Advisors
32
Citadel Advisors
Florida
$563K -$59K -11,590 -8%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$404K -$584K -114,900 -54%
Charles Schwab
34
Charles Schwab
California
$395K +$29.2K +5,738 +7%
Bank of America
35
Bank of America
North Carolina
$389K +$189K +37,123 +67%
GCP
36
GSA Capital Partners
United Kingdom
$389K +$335K +65,842 +246%
BCM
37
Bridgeway Capital Management
Texas
$385K -$127K -24,917 -21%
Two Sigma Investments
38
Two Sigma Investments
New York
$286K -$89K -17,487 -20%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$250K -$121K -23,755 -29%
Mirae Asset Global Investments
40
Mirae Asset Global Investments
South Korea
$233K
Goldman Sachs
41
Goldman Sachs
New York
$226K +$99.2K +19,499 +57%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$193K +$12.8K +2,518 +6%
Squarepoint
43
Squarepoint
New York
$179K +$217K +42,607 New
Walleye Capital
44
Walleye Capital
New York
$147K -$1.05M -206,013 -85%
BC
45
BIT Capital
Germany
$122K
DA
46
Denali Advisors
California
$112K
Morgan Stanley
47
Morgan Stanley
New York
$111K -$36.7K -7,213 -21%
JP Morgan Chase
48
JP Morgan Chase
New York
$92.4K -$21.9K -4,305 -16%
AQR Capital Management
49
AQR Capital Management
Connecticut
$82.9K +$100K +19,744 New
UBS Group
50
UBS Group
Switzerland
$79.5K -$13.5K -2,660 -12%